Ted Love is the president and CEO of Global Blood Therapeutics. In his conversation with Nature Biotechnology, he discusses why his time at Haverford College was transformative, why he views Global Blood Therapeutics as a social justice company, and what might be gained from the “racial catharsis” happening in America after the police killing of George Floyd.
About this article
Cite this article
First Rounders: Ted Love. Nat Biotechnol 38, 943 (2020). https://doi.org/10.1038/s41587-020-0617-x